| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/06/2013 | CN102949481A Health care tea for reducing blood pressure and blood lipid |
| 03/06/2013 | CN102949463A Traditional Chinese medicine composition for reducing blood fat |
| 03/06/2013 | CN102949459A Medicinal composition for reducing blood sugar and capsule preparation method of the medicinal composition |
| 03/06/2013 | CN102949447A Traditional Chinese medicine for treating diabetic neuropathy and preparation method thereof |
| 03/06/2013 | CN102949437A Traditional Chinese medicine for treating diabetic retinopathy and preparation method thereof |
| 03/06/2013 | CN102949435A Application of persimmon leaf general flavone in inhibiting pancreatic beta cell apoptosis and extraction method thereof |
| 03/06/2013 | CN102949433A Pure traditional Chinese medicinal health care product syrup used for assisting in reducing blood fat and preparation method thereof |
| 03/06/2013 | CN102949420A Preparation method of medicinal flavonoid by ginkgo leaf extraction |
| 03/06/2013 | CN102949415A Propolis fat emulsion preparation and preparation method thereof |
| 03/06/2013 | CN102949413A Method for preparing invert sugar and electrolytes injection |
| 03/06/2013 | CN102949396A Method for processing medicament for relieving animal transportation stress response |
| 03/06/2013 | CN102949375A Berberine hydrochloride solid lipid nano preparation and preparation method thereof |
| 03/06/2013 | CN102949366A Nicotinic acid slow-release tablet composition |
| 03/06/2013 | CN102949363A Ursolic acid liquid-solid compression tablet |
| 03/06/2013 | CN102949361A Oral solid medicinal composition for treating hyperlipidemia and preparation method thereof |
| 03/06/2013 | CN102949360A Solid pharmaceutical composition for buccal administration of agomelatine |
| 03/06/2013 | CN102948758A Method for extracting buckwheat flavone from buckwheat bran |
| 03/06/2013 | CN102948622A Aquatic animal oral nutritional medicine with food luring and growth-promoting effects and its preparation method |
| 03/06/2013 | CN102948504A Sobering-up and alcoholism relieving tea and its use |
| 03/06/2013 | CN102948429A Livin bacteria removing liquid for marine organism |
| 03/06/2013 | CN102552155B Lidocaine nanometer calcium phosphate preparation and preparation method thereof |
| 03/06/2013 | CN102429864B Medicinal compound of fat-soluble vitamin injection (II) and water-soluble vitamin for injection and preparation method thereof |
| 03/06/2013 | CN102429055B Weight reducing tea |
| 03/06/2013 | CN102351959B Preparation method and application of multiflower knotweed vine polysaccharide chelate zinc |
| 03/06/2013 | CN102240310B Blood-sugar-reducing composition and preparation method thereof |
| 03/06/2013 | CN102228423B Tolvaptan oral solid medicinal composition and preparation method thereof |
| 03/06/2013 | CN102218058B Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy |
| 03/06/2013 | CN102178718B Preparation used for treating diabetes mellitus and preventively treating heart cerebrovascular disease |
| 03/06/2013 | CN102178662B Insulin carrier transdermal drug delivery preparation and preparation method thereof |
| 03/06/2013 | CN102018766B Plant extractive, extraction method and application thereof as well as composite comprising same |
| 03/06/2013 | CN101966174B Pharmaceutical application of p-bromocinnamoyl silybin to preparing glycosidase inhibitors |
| 03/06/2013 | CN101884675B Food therapy preparation for preventing and treating hyperlipidemia based on theories of preventive treatment of disease and medicine food homology |
| 03/06/2013 | CN101817833B DPP-IV inhibitor |
| 03/06/2013 | CN101780081B Niacin and simvastatin composition sustained-release tablet |
| 03/06/2013 | CN101743232B Compounds and methods for modulating fxr |
| 03/06/2013 | CN101732545B Preparation of compound extract of anemarrhena, astragalus and bitter gourd and use thereof |
| 03/06/2013 | CN101679236B Process for the preparation of ezetimibe and derivatives thereof |
| 03/06/2013 | CN101643451B Peroxisome proliferator-activated receptor subtype delta agonist compound and preparation method thereof |
| 03/06/2013 | CN101613340B Hazel endothelin and extracting method and drug application thereof |
| 03/06/2013 | CN101098859B Pyrimidinone compound, preparation and application thereof |
| 03/06/2013 | CN101010101B Composition comprising protein material and non-oxidizable fatty acid entities |
| 03/05/2013 | US8389546 Compounds for modulating TRPV3 function |
| 03/05/2013 | US8389500 Fused heterocyclic compounds as ion channel modulators |
| 03/05/2013 | US8389470 Methods and compositions for delivering peptides |
| 03/05/2013 | US8389279 α-aminocyclolactam ligands for G-protein coupled receptors, and methods of using same |
| 03/05/2013 | US8389011 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/05/2013 | US8389006 Pharmaceutical compositions of adsorbates of amorphous drug |
| 03/05/2013 | US8389003 Ingestible implement for weight control |
| 03/05/2013 | US8388935 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 03/05/2013 | CA2569883C Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 03/05/2013 | CA2529320C Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
| 03/01/2013 | CA2844073A1 Policosanol nanoparticles |
| 02/28/2013 | WO2013028555A2 Methods for weight loss and ketogenic compositions |
| 02/28/2013 | WO2013028017A2 Composition containing silk fibroin having a high molecular weight for lowering blood sugar and cholesterol, and a method of producing same |
| 02/28/2013 | WO2013027794A1 Novel compound and use thereof as pde10 inhibitor |
| 02/28/2013 | WO2013027188A1 2 -amino-4 - (pyridin- 2 -yl) - 5, 6 -dihydro-4h- 1, 3 -oxazine derivatives and their use as bace-1 and/or bace - 2 inhibitors |
| 02/28/2013 | WO2013026587A1 1,4 disubstituted pyrrolidine - 3 - yl -amine derivatives and their use for the treatment of metabolic disorders |
| 02/28/2013 | WO2013026264A1 Cb1 acceptor inhibitor compound with nitrogen-containing aromatic ring having hydroxyl and use thereof |
| 02/28/2013 | WO2013026118A1 Ready-to-use electrolyte formulation, ready-to-use bag, kit, uses and method for treating kidney failure |
| 02/28/2013 | WO2013026099A1 Fn14 binding proteins and uses thereof |
| 02/28/2013 | WO2013026089A1 Peptides for use in the treatment of il-1 related diseases and conditions |
| 02/28/2013 | WO2012149157A3 Heterocyclic compounds for the inhibition of pask |
| 02/28/2013 | WO2012138146A3 Composition containing heat-treated powder or extract of glycine soja as active gradient for prevention and treatment of diabetes mellitus and diabetic complications |
| 02/28/2013 | US20130053446 Pharmaceutical preparations having individualized dosage and structure |
| 02/28/2013 | US20130053443 Method for preparing extract containing omega fatty acids from plant by using supercritical carbon dioxide extraction |
| 02/28/2013 | US20130053442 Balanced myristate- and laurate-containing edible oil |
| 02/28/2013 | US20130053431 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 02/28/2013 | US20130053430 Modulation of cetp expression |
| 02/28/2013 | US20130053417 Cetp activity inhibitors |
| 02/28/2013 | US20130053414 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate |
| 02/28/2013 | US20130053412 Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use |
| 02/28/2013 | US20130053404 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 02/28/2013 | US20130053402 Substituted 3-thiazoloamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/28/2013 | US20130053401 Thieno [2,3-b] pyridinedione activators of ampk and therapeutic uses thereof |
| 02/28/2013 | US20130053398 Modulators of fatty acid amide hydrolase |
| 02/28/2013 | US20130053395 Pyrazolopyridine kinase inhibitors |
| 02/28/2013 | US20130053394 Pyrazolopyrimidine kinase inhibitors |
| 02/28/2013 | US20130053388 Pyrazolopyrazine kinase inhibitors |
| 02/28/2013 | US20130053380 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 02/28/2013 | US20130053379 4-aryl-2-anilino-pyrimidines |
| 02/28/2013 | US20130053378 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use |
| 02/28/2013 | US20130053371 Inhibitors of pi3 kinase |
| 02/28/2013 | US20130053369 Tetrahydrobenzothiophene compound |
| 02/28/2013 | US20130053367 Compounds and methods of treating diabetes |
| 02/28/2013 | US20130053366 Compounds and methods for treatment of hypertension |
| 02/28/2013 | US20130053364 Sulphone Compounds and Methods of Making and Using Same |
| 02/28/2013 | US20130053360 Controlled release and taste masking oral pharmaceutical composition |
| 02/28/2013 | US20130053356 2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3 |
| 02/28/2013 | US20130053346 Pyrimido-pyridazinone compounds and methods of use thereof |
| 02/28/2013 | US20130053345 Bicyclic heteroarly analogues as gpr119 modulators |
| 02/28/2013 | US20130053344 Synthesis of pyrrolidine compounds |
| 02/28/2013 | US20130053336 Treatment of chlamydiaceae infections by means of beta-lactams |
| 02/28/2013 | US20130053332 Use |
| 02/28/2013 | US20130053317 Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection |
| 02/28/2013 | US20130053315 Novel glp-1 derivatives |
| 02/28/2013 | US20130053313 New formulation for increasing bioavailability of neurturin |
| 02/28/2013 | US20130053311 Glp-1 analogues and derivatives |
| 02/28/2013 | US20130053310 Novel glucagon analogues |
| 02/28/2013 | US20130053309 Substituted diketopiperazine analogs for use as drug delivery agents |
| 02/28/2013 | US20130053308 4-AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2a RECEPTOR ANTAGONISTS |